Cargando…
Delivering the message: How a novel technology enabled the rapid development of effective vaccines
This year’s Lasker∼Debakey Clinical Research Award honors Katalin Karikó and Drew Weissman for the development of a therapeutic technology based on nucleoside-modification of messenger RNA, enabling the rapid development of the highly effective COVID-19 vaccines.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462133/ https://www.ncbi.nlm.nih.gov/pubmed/34562362 http://dx.doi.org/10.1016/j.cell.2021.08.019 |
| _version_ | 1784572135026458624 |
|---|---|
| author | Shapiro, Lucy Losick, Richard |
| author_facet | Shapiro, Lucy Losick, Richard |
| author_sort | Shapiro, Lucy |
| collection | PubMed |
| description | This year’s Lasker∼Debakey Clinical Research Award honors Katalin Karikó and Drew Weissman for the development of a therapeutic technology based on nucleoside-modification of messenger RNA, enabling the rapid development of the highly effective COVID-19 vaccines. |
| format | Online Article Text |
| id | pubmed-8462133 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84621332021-09-27 Delivering the message: How a novel technology enabled the rapid development of effective vaccines Shapiro, Lucy Losick, Richard Cell BenchMarks This year’s Lasker∼Debakey Clinical Research Award honors Katalin Karikó and Drew Weissman for the development of a therapeutic technology based on nucleoside-modification of messenger RNA, enabling the rapid development of the highly effective COVID-19 vaccines. Elsevier Inc. 2021-10-14 2021-09-24 /pmc/articles/PMC8462133/ /pubmed/34562362 http://dx.doi.org/10.1016/j.cell.2021.08.019 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | BenchMarks Shapiro, Lucy Losick, Richard Delivering the message: How a novel technology enabled the rapid development of effective vaccines |
| title | Delivering the message: How a novel technology enabled the rapid development of effective vaccines |
| title_full | Delivering the message: How a novel technology enabled the rapid development of effective vaccines |
| title_fullStr | Delivering the message: How a novel technology enabled the rapid development of effective vaccines |
| title_full_unstemmed | Delivering the message: How a novel technology enabled the rapid development of effective vaccines |
| title_short | Delivering the message: How a novel technology enabled the rapid development of effective vaccines |
| title_sort | delivering the message: how a novel technology enabled the rapid development of effective vaccines |
| topic | BenchMarks |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462133/ https://www.ncbi.nlm.nih.gov/pubmed/34562362 http://dx.doi.org/10.1016/j.cell.2021.08.019 |
| work_keys_str_mv | AT shapirolucy deliveringthemessagehowanoveltechnologyenabledtherapiddevelopmentofeffectivevaccines AT losickrichard deliveringthemessagehowanoveltechnologyenabledtherapiddevelopmentofeffectivevaccines |